Sophie Nash

12PUBLICATIONS
57CO-AUTHORS
English as a second languageGene expression (incl. microarray and other genome-wide approaches)Epidemiological modellingGenetically modified animalsSurgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 31, 2023
Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1 compared to BA.5 in England.

Giulia Seghezzo, Sophie G Nash, Nurin A Aziz

|Sep 19, 2023
Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.

Katherine A Twohig, Katie Harman, Asad Zaidi

|May 28, 2023
Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England.

Katie Harman, Sophie Grace Nash, Harriet H Webster

|Mar 20, 2023
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.

Hester Allen, Elise Tessier, Charlie Turner

|Feb 20, 2022
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.

Tommy Nyberg, Katie Harman, Asad Zaidi

|Sep 16, 2021
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England.

Alison E Brown, Sara E Croxford, Sophie Nash

Pageof 2

Frequent Collaborators

4 joint publications

Valerie Delpech

3 joint publications

Meera Chand

3 joint publications

Gavin Dabrera

3 joint publications

Peter Kirwan